News Features After DanGer Shock’s Win in AMICS for Impella: What’s Next? Caitlin E. Cox May 02, 2024
News Features Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path Michael O'Riordan January 17, 2022
News Features FFR’s Future: Negative Trials Spur Debate Over Technology’s Role Michael O'Riordan December 23, 2021
News Features US Chest Pain Guidelines Will Change Practice, Though Gaps Remain Yael L. Maxwell December 06, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021
News Features ‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19 Michael O'Riordan April 07, 2020
News Features To RCT or Not to RCT? Impella Debate Pivots on How Best to Study Patients on the Brink of Death Caitlin E. Cox May 02, 2018